Comment on "Adaptive versus fixed designs in confirmatory clinical trials: Centering the choice on ethics". [PDF]
Senn S.
europepmc +1 more source
Multiclass HIV drug resistance: Case series of treatment-experienced PLHIV with resistance to all antiretroviral classes in Northern Uganda. [PDF]
Kayinda F +4 more
europepmc +1 more source
Association between infant post-natal prophylaxis regimens and pretreatment HIV drug resistance in infected infants. [PDF]
Inzaule SC +14 more
europepmc +1 more source
Early outcomes of South African children with persistent viral non-suppression following switch to dolutegravir-based antiretroviral therapy. [PDF]
Guerrini M +8 more
europepmc +1 more source
Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events". [PDF]
Fleming TR +6 more
europepmc +1 more source
Pharmacovigilance signals for congenital heart disease related to drug exposure: A disproportionality analysis based on the FAERS database. [PDF]
He CL +5 more
europepmc +1 more source
Efficacy and safety of TDF+3TC + EFV‑centric antiretroviral regimens for HIV/HBV co-infection: a systematic review and network meta‑analysis. [PDF]
Zhang X +6 more
europepmc +1 more source
Congenital Infections as Risk Factor for Adverse Birth Outcomes among HIV-Exposed Neonates in Uganda. [PDF]
Atuhaire P +6 more
europepmc +1 more source
Comparative evaluation of human T lymphocytes in HIV patients treated with lamivudine + zidovudine combined with nevirapine versus efavirenz. [PDF]
Zhu X, Zou M.
europepmc +1 more source

